Alamar Biosciences, Inc. · NASDAQ:ALMR
Qiming Corporate GP VI, Ltd. sold 100,117 Alamar Biosciences, Inc. shares (Form 4)
Traded Nov 11, 2026 · Filed Nov 13, 2026
On Nov 11, 2026, Qiming Corporate GP VI, Ltd. (10% owner) sold 100,117 Alamar Biosciences, Inc. shares at an average US$29.38 for US$2.94M, leaving 1,632,188 shares. Filed Nov 13, 2026 (Form 4).
- Sold
- 100,117 shares
- Price
- US$29.38 average (US$29.34 to US$30.63)
- Value
- US$2.94M
- Holding after
- 1,632,188 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Common Stock | Sale | 1,694 | US$29.34 | 157,273 | Indirect |
| Nov 11, 2026 | Common Stock | Sale | 56 | US$30.63 | 157,217 | Indirect |
| Nov 11, 2026 | Common Stock | Sale | 62,944 | US$29.34 | 5,844,859 | Indirect |
| Nov 11, 2026 | Common Stock | Sale | 2,084 | US$30.63 | 5,842,775 | Indirect |
| Nov 11, 2026 | Common Stock | Sale | 14,687 | US$29.34 | 1,363,787 | Indirect |
| Nov 11, 2026 | Common Stock | Sale | 486 | US$30.63 | 1,363,301 | Indirect |
| Nov 11, 2026 | Common Stock | Sale | 17,584 | US$29.34 | 1,632,770 | Indirect |
| Nov 11, 2026 | Common Stock | Sale | 582 | US$30.63 | 1,632,188 | Indirect |
Source
Download original · View original at SEC
Related
- Alamar Biosciences, Inc.
- Qiming Corporate GP VI, Ltd.
- Alamar Biosciences, Inc. shareholders
- Form 4 · Qiming Corporate GP VI, Ltd. · Nov 5, 2026
- Form 4 · Qiming Corporate GP VI, Ltd. · Nov 3, 2026
- Form 4 · Qiming Corporate GP VI, Ltd. · Oct 29, 2026
- Form 4 · Qiming Corporate GP VI, Ltd. · Oct 27, 2026
- Form 4 · Qiming Corporate GP VI, Ltd. · Oct 23, 2026
- Schedule 13G · Yuling Luo · Aug 13, 2026
- Schedule 13G · Qiming Corporate GP VI, Ltd. · Aug 11, 2026
- Schedule 13D/A · Sands Capital Life Sciences Pulse Fund II, L.P. · Jul 7, 2026
- Schedule 13G · Daqing Cai · Jul 2, 2026
- Schedule 13D · Nicholas Naclerio · Apr 23, 2026